Beth Nordstrom

3.6k total citations · 1 hit paper
80 papers, 2.8k citations indexed

About

Beth Nordstrom is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Beth Nordstrom has authored 80 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Beth Nordstrom's work include Lung Cancer Treatments and Mutations (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Advanced Breast Cancer Therapies (5 papers). Beth Nordstrom is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Advanced Breast Cancer Therapies (5 papers). Beth Nordstrom collaborates with scholars based in United States, United Kingdom and Switzerland. Beth Nordstrom's co-authors include Judith A. Hall, Debra Roter, Bonnie L. Svarstad, Harry A. Quigley, Essy Mozaffari, David S. Friedman, Alexander M. Walker, Jason C. Simeone, Kyle Fahrbach and Susan D. Ross and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Beth Nordstrom

78 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Interventions to Improve Patient Compliance

1998 799 citations Beth Nordstrom et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Nordstrom United States	23	457	381	361	342	312	80	2.8k
Tessa Kennedy‐Martin United States	18	427 0.9×	156 0.4×	317 0.9×	84 0.2×	89 0.3×	28	2.1k
Alexis Ogdie United States	42	55 0.1×	330 0.9×	474 1.3×	344 1.0×	137 0.4×	291	7.6k
Mary A. De Vera Canada	35	48 0.1×	426 1.1×	423 1.2×	384 1.1×	236 0.8×	160	3.9k
Kristijan H. Kahler United States	27	52 0.1×	192 0.5×	250 0.7×	194 0.6×	625 2.0×	72	2.9k
Stephen S. Johnston United States	28	61 0.1×	168 0.4×	329 0.9×	336 1.0×	94 0.3×	135	3.2k
Kristina S. Boye United States	34	102 0.2×	129 0.3×	427 1.2×	84 0.2×	347 1.1×	164	3.8k
Andrew P. Yu United States	33	60 0.1×	201 0.5×	1.1k 3.0×	194 0.6×	140 0.4×	80	3.7k
Alan Rosenberg Canada	30	147 0.3×	252 0.7×	210 0.6×	98 0.3×	22 0.1×	110	3.2k
Christopher Ll. Morgan United Kingdom	32	45 0.1×	290 0.8×	398 1.1×	267 0.8×	128 0.4×	80	3.4k
Melissa G. Butler United States	24	57 0.1×	96 0.3×	198 0.5×	152 0.4×	140 0.4×	64	1.7k

Countries citing papers authored by Beth Nordstrom

Since Specialization

Citations

This map shows the geographic impact of Beth Nordstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Nordstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Nordstrom more than expected).

Fields of papers citing papers by Beth Nordstrom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Nordstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Nordstrom. The network helps show where Beth Nordstrom may publish in the future.

Co-authorship network of co-authors of Beth Nordstrom

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Nordstrom. A scholar is included among the top collaborators of Beth Nordstrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Nordstrom. Beth Nordstrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fabricatore, Anthony N., et al.. (2025). Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months). Postgraduate Medicine. 137(3-4). 251–260. 4 indexed citations

Iyer, Renuka, Kathryn Evans, Alyssa Klein, et al.. (2025). Real-world assessment of MDM2 amplification and survival among patients with advanced or metastatic biliary tract cancer in the United States.. Journal of Clinical Oncology. 43(4_suppl). 544–544. 1 indexed citations

Jakes, Rupert W., Namhee Kwon, Beth Nordstrom, et al.. (2021). Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis. Clinical Rheumatology. 40(12). 4829–4836. 36 indexed citations

Caballero, A. Enrique, Beth Nordstrom, Birong Liao, et al.. (2021). Individualized HbA1c target selection and achievement in the Multinational Observational Study Assessing Insulin Use (MOSA1c) type 2 diabetes study. Journal of Diabetes and its Complications. 35(11). 108011–108011. 1 indexed citations

Golozar, Asieh, Jenna Collins, Kathy Fraeman, et al.. (2019). OA07.02 LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World. Journal of Thoracic Oncology. 14(10). S223–S224. 4 indexed citations

Berger, Ariel, Alex Simpson, Tarun Bhagnani, et al.. (2019). Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease. The American Journal of Cardiology. 123(12). 1893–1899. 36 indexed citations

Ray, Kausik K., David M. Kendall, Zhenxiang Zhao, et al.. (2018). A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy. Diabetes Obesity and Metabolism. 21(5). 1101–1110. 7 indexed citations

Carroll, Robert, Dimitra Lambrelli, Robert M. Donaldson, et al.. (2018). PCV138 - TREATMENT PATTERNS OF PATIENTS WITH VENOUS THROMBOEMBOLISM TREATED WITH ORAL ANTICOAGULANTS IN ENGLAND. Value in Health. 21. S115–S115. 1 indexed citations

Graham, Sophie, Mireia Raluy-Callado, Robert M. Donaldson, et al.. (2018). PCV116 - DISCONTINUATION AND HEALTH CARE RESOURCE UTILISATION IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN OR WARFARIN IN ENGLAND. Value in Health. 21. S112–S112. 1 indexed citations

10.

Malatestinic, William N., Beth Nordstrom, Jashin J. Wu, et al.. (2017). Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials. Journal of Managed Care & Specialty Pharmacy. 23(3). 370–381. 16 indexed citations

11.

Simeone, Jason C., Jay Bae, Byron J. Hoogwerf, et al.. (2017). Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes. Clinical Epidemiology. Volume 9. 679–688. 27 indexed citations

12.

Capkun, Gorana, Frank Dahlke, Raquel Lahoz, et al.. (2015). Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Multiple Sclerosis and Related Disorders. 4(6). 546–554. 90 indexed citations

13.

Simeone, Jason C., Elizabeth Marrett, Feride Frech‐Tamas, et al.. (2015). One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel. American Journal of Cardiovascular Drugs. 15(5). 337–350. 18 indexed citations

14.

Capkun-Niggli, Gorana, Raquel Lahoz, E. Verdun, et al.. (2013). Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis. Value in Health. 16(7). A582–A582. 4 indexed citations

15.

Capkun-Niggli, Gorana, Raquel Lahoz, Beth Nordstrom, et al.. (2013). Exploring the Identification of Multiple Sclerosis Incident Cohorts in Claims Databases: Methodology and Challenges. Value in Health. 16(7). A582–A582. 1 indexed citations

16.

Nordstrom, Beth, Jason C. Simeone, Zhenxiang Zhao, et al.. (2013). Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention. American Journal of Cardiovascular Drugs. 13(4). 263–271. 20 indexed citations

17.

Citrome, Leslie, Jenna Collins, Beth Nordstrom, et al.. (2013). Incidence of Cardiovascular Outcomes and Diabetes Mellitus Among Users of Second-Generation Antipsychotics. The Journal of Clinical Psychiatry. 74(12). 1199–1206. 22 indexed citations

18.

Luo, Weixiu, Beth Nordstrom, Kathy Fraeman, et al.. (2008). Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: Results of a retrospective study of an electronic medical-records database in the United States, 2002–2006. Clinical Therapeutics. 30(12). 2423–2435. 10 indexed citations

19.

Nordstrom, Beth, David S. Friedman, Essy Mozaffari, Harry A. Quigley, & Alexander M. Walker. (2005). Persistence and Adherence With Topical Glaucoma Therapy. American Journal of Ophthalmology. 140(4). 598.e1–598.e11. 380 indexed citations

20.

Kinnunen, Taru, Harold S. Zamansky, & Beth Nordstrom. (2001). Is the hypnotized subject complying?. International Journal of Clinical and Experimental Hypnosis. 49(2). 83–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact